After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KYTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Kyverna Therapeutics Inc is $205.30M. A total of 0.67 million shares were traded on the day, compared to an average of 363.12K shares.
In the most recent transaction, Vida Ventures, LLC bought 253,136 shares of KYTX for 22.00 per share on Feb 12 ’24. After the transaction, the 10% Owner now owns 252,553 company shares. In a previous transaction on Feb 12 ’24, Bain Capital Life Sciences Inv bought 450,000 shares at 22.00 per share. KYTX shares that 10% Owner owns now total 3,163,868.
Among the insiders who bought shares, GILEAD SCIENCES, INC. acquired of 910,000 shares on Feb 12 ’24 at a per-share price of $22.00. This resulted in the 10% Owner holding 4,126,119 shares of KYTX after the transaction. In another insider transaction, Northpond Ventures III GP, LLC bought 450,000 shares at $22.00 per share on Feb 12 ’24. Company shares held by the Former 10% Owner now total 450,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KYTX has a high of $35.06 and a low of $3.92.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KYTX’s latest balance sheet shows that the firm has $76.07M in Cash & Short Term Investments as of fiscal 2021. There were $5.55M in debt and $15.93M in liabilities at the time. Its Book Value Per Share was $7.01, while its Total Shareholder’s Equity was $-46.25M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYTX is Buy with a score of 4.71.
